VASTox signs two drug discovery collaboration deals worth a combined EUR 1 Million
Collaborations with Rottapharm and an unnamed European biotech company leverage on VASTox's zebrafish chemical genomics platform and medicinal chemistry expertise
15-Feb-2007 -
VASTox plc announced that it has signed two long-term chemical genomics deals with a combined value of EUR1 million. The first deal sees VASTox entering into a long-term drug discovery and toxicology screening collaboration with the multinational pharmaceutical company Rottapharm S.p.A. The total ...
biotechnology
collaborations
drug discovery collaborations
+5